FLXN Chart
- 52-Week Range: $4.40 - $13.09
- Market Capitalization: $461.49M
- Short Percentage: 0%
- Target Price: $27.00
- Shares Outstanding: 50.32M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Flexion Therapeutics, Inc.PRNewsWire | October 11th
- Flexion Therapeutics shares soar 39% premarket on news to be acquired by Pacira BiosciencesMarket Watch | October 11th
- Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | October 1st
- Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire | September 8th
- Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare ConferenceGlobeNewsWire | September 3rd
- Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha | August 4th
Company Info
Website: http://www.flexiontherapeutics.com
Address: 10 Mall Road, Burlington, MA, United States, 01803
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 257
Address: 10 Mall Road, Burlington, MA, United States, 01803
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 257
$FLXN nice day!
$FLXN somebody knows something
$FLXN has just been halted from trading.
$FLXN has just been halted from trading.
$FLXN If options never existed
what do you think this stock would be trading at?
$FLXN watch for a morning dip and rip
$FLXN The stock market is the biggest joke.
$FLXN Time for this bitch to blow